Drug intelligence / Profile preview

ginsenoside Rb2

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Ginsenoside Rb2** is a natural protopanaxadiol-type saponin found in *Panax ginseng* and related ginseng species[1][5][3]. It is a major active component of ginseng extracts and is distributed in roots, stems, and leaves. Rb2 exhibits diverse pharmacological activities in preclinical models, including anti-diabetic, anti-obesity, anti-inflammatory, anti-cancer, antioxidative, anti-osteoporosis, and antiviral actions[1][3][4][7]. Mechanistic studies show Rb2 inhibits oxidative stress, inflammation, and apoptosis by modulating signaling pathways and molecular targets such as AMPK, AKT, MAPK, NF-κB, SIRT1, EGFR/SOX2, TGF-β1/Smad, GPR120/AMPK/HO-1, and miR-216a[1][2][7]. Rb2 promotes insulin sensitivity, glucose uptake, activates brown adipose tissue, and reduces cholesterol and triglyceride levels[1][4][5]. Despite promising preclinical evidence, clinical data for Rb2 as an isolated drug are limited; human studies primarily use ginseng extracts and confirm low bioavailability and slow elimination[1]. No clinical approvals currently exist for any indication.

Other names
ginsenoside Rb2G-Rb2G-Rb-2G-Rb 2Ginsenoside C
02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)MEKNF-κBAKT (RAC-alpha serine/threonine-protein kinase)NR0B2 (Small heterodimer partner)

Beyond the preview

Go deeper on ginsenoside Rb2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside Rb2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call